Allergy clinic patients' drug hypersensitivity

被引:2
作者
Frachowicz-Guerreiro, Karolina [1 ]
Wardzynska, Aleksandra [1 ]
Kowalski, Marek L. [1 ]
机构
[1] Med Univ Lodz, Immunol & Allergy Clin, Lodz, Poland
关键词
Anaphylaxis; B-lactams; drug hypersensitivity; drug provocation and tolerance tests; NSAIDs; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; INDUCED ANAPHYLAXIS; REVISED NOMENCLATURE; EPIDEMIOLOGY; MELOXICAM; DIAGNOSIS; SAFETY; CLASSIFICATION; ORGANIZATION; PATTERNS;
D O I
10.15586/aei.v50i3.10
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Drug hypersensitivity reaction (DHR) is a common reason for an allergology consultation, during which it is not only necessary to gather a thorough medical history, but also to propose and perform diagnostic tests. Objectives: The aim of the study was to retrospectively assess the patients with a profile of preliminary drug hypersensitivity diagnosis, the usefulness of NSAID hypersensitivity classification in outpatient practice, and to analyze the results of skin, provocation, and drug tolerance tests performed in Immunology and Allergy Clinic patients. Methods: Around 501 medical records of patients referred to the academic allergy outpatient clinic from 2011 to 2019, and had a preliminary drug hypersensitivity diagnosis were analyzed. The diagnostic and drug tolerance tests results carried out in 269 patients of the Clinic from 2009 to 2019 were then evaluated. Results: Among the patients referred due to suspected drug hypersensitivity, the majority (n=338, 67.5%) were believed to be hypersensitive to NSAIDs and antibiotics (n=272, 54.3%). In patients with hypersensitivity to NSAIDs, the mixed pattern was the most prevalent (n=73, 21.6%), followed by NECD (n=64, 18.9%) and NIUA (n=55, 16.3%). The second most common drug causing DHR were the antibiotics, mainly beta-lactams (n=160, 58.8%), followed by macrolides (n=35, 12.9%). In hypersensitivity caused due to beta-lactams, the delayed form was predominant (n=24, 15%) with manifested skin symptoms (n=74, 46.3%). Non-steroidal anti-inflammatory drugs (n=21, 42.9%), followed by antibiotics (n=11, 22.5%) were the commonest causes of anaphylaxis, as reported by 49 patients. Conclusion: The study shows that a majority of patients with suspected drug hypersensitivity can be classified under the hypersensitivity umbrella based on their medical history, which is the basis for further diagnostic process.
引用
收藏
页码:77 / 84
页数:8
相关论文
共 47 条
  • [1] Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations
    Aberer, W
    Bircher, A
    Romano, A
    Blanca, M
    Campi, P
    Fernandez, J
    Brockow, K
    Pichler, WJ
    Demoly, P
    [J]. ALLERGY, 2003, 58 (09) : 854 - 863
  • [2] Immediate hypersensitivity reactions to penicillins and other betalactams
    Antunez, C.
    Martin, E.
    Cornejo-Garcia, J. A.
    Blanca-Lopez, N.
    R-Pena, R.
    Mayorga, C.
    Torres, M. J.
    Blanca, M.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (26) : 3327 - 3333
  • [3] Aun MV, 2014, J ALLER CL IMM-PRACT, V2, P414, DOI [10.1016/j.jaip.2014.08.015, 10.1016/j.jaip.2014.03.014]
  • [4] Anaphylaxis in Elderly Patients-Data From the European Anaphylaxis Registry
    Aurich, Stefanie
    Doelle-Bierke, Sabine
    Francuzik, Wojciech
    Bilo, Maria Beatrice
    Christoff, George
    Fernandez-Rivas, Montserrat
    Hawranek, Thomas
    Pfoehler, Claudia
    Poziomkowska-Gesicka, Iwona
    Renaudin, Jean-Marie
    Oppel, Eva
    Scherer, Kathrin
    Treudler, Regina
    Worm, Margitta
    Gruenhagen, J.
    Beyer, K.
    Moeser, A.
    Fuchs, T.
    Rueff, F.
    Knop, M.
    Wedi, B.
    Dickel, H.
    Merk, H.
    Hillen, U.
    Bauer, A.
    Wagner, N.
    Rietschel, E.
    Klimek, L.
    Pfaar, O.
    Reider, N.
    Aberer, W.
    Koehli, A.
    Riffelmann, F.
    Kroft, B.
    Nemat, K.
    Kinaciyan, T.
    Brehler, R.
    Witte, J.
    Hunzelmann, N.
    Huseynow, I
    Bieber, T.
    Rabe, U.
    Schmid-Grendelmeier, P.
    Brosi, W.
    Nestoris, S.
    Lang, R.
    Bruns, R.
    Lehmann, S.
    Lange, L.
    Hansen, G.
    [J]. FRONTIERS IN IMMUNOLOGY, 2019, 10 : 750
  • [5] Under-reporting of serious adverse drug reactions in Sweden
    Bäckström, M
    Mjörndal, T
    Dahlqvist, R
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2004, 13 (07) : 483 - 487
  • [6] Safety of selective COX-2 inhibitors in aspirin/nonsteroidal anti-inflammatory drug-intolerant patients:: Comparison of nimesulide, meloxicam, and rofecoxib
    Bavbek, S
    Çelik, G
    Özer, F
    Mungan, D
    Misirligil, Z
    [J]. JOURNAL OF ASTHMA, 2004, 41 (01) : 67 - 75
  • [7] Safety of meloxicam in aspirin-hypersensitive patients with asthma and/or nasal polyps - A challenge-proven study
    Bavbek, Sevim
    Dursun, A. Berna
    Dursun, Engin
    Eryilmaz, Adil
    Misirligil, Zeynep
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2007, 142 (01) : 64 - 69
  • [8] Blanca-López N, 2015, J INVEST ALLERG CLIN, V25, P385
  • [9] Antibiotic allergy
    Blumenthal, Kimberly G.
    Peter, Jonny G.
    Trubiano, Jason A.
    Phillips, Elizabeth J.
    [J]. LANCET, 2019, 393 (10167) : 183 - 198
  • [10] Epidemiology of Adverse Drug Reactions in Europe: A Review of Recent Observational Studies
    Bouvy, Jacoline C.
    De Bruin, Marie L.
    Koopmanschap, Marc A.
    [J]. DRUG SAFETY, 2015, 38 (05) : 437 - 453